Abbott Laboratories vs. Spyre Therapeutics, Inc. Common Stock
Abbott Laboratories and Spyre Therapeutics, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | SYRE | |
|---|---|---|
| Market Cap | $177.55 billion | $7.52 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | SYRE | |
|---|---|---|
| Dividend Yield | 2.46% | — |
ABT and SYRE split the dividend factors evenly.
Risk & Sentiment
| ABT | SYRE | |
|---|---|---|
| Short Interest | 0.57% | 0.20% |
SYRE leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, SYRE overview, SYRE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.